ArticleJAMA neurology2023

Prevalence and Clinical Implications of a β-Amyloid-Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease.

Pontus Erickson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.